Las Vegas-based tech startup Regara can cut the time-consuming FDA approval process in half, which, for a drug like Ozempic, ...
Food and Drug Administration chief Dr. Marty Makary resigned Tuesday after a tumultuous 13 months leading the agency charged ...
During a tumultuous 13-month tenure at the FDA, Makary pursued a wide range of ambitious initiatives. Going forward, their status under the next commissioner is unclear.
The federal Food and Drug Administration nannies have been tormenting Americans for decades, which is no surprise given the pitfalls of putting bureaucrats in charge of such an important function as ...
FDA announced version 4.0 of Elsa, its internal AI chatbot for staff, and a new internal data platform called Harmonized AI & Lifecycle Operations ...
The U.S. Food and Drug Administration (FDA) announced a new process called “Rare Disease Evidence Principles” (RDEP), under which eligible drugs and biologics for ultra-rare diseases caused by known ...
Makary's tenure was marked by internal dysfunction at the FDA, leadership turmoil and mounting backlash from drugmakers and physicians on regulatory decisions.
In an ideal world, this week’s resignation of Food and Drug Administration Commissioner Marty Makary would signal the end of a troubling period at the agency — one where the job of overseeing a ...
According to the Food and Drug Administration (FDA), the traditional paradigm of medical device regulation was not designed for adaptive artificial intelligence and machine learning technologies. As a ...
The US Food and Drug Administration (FDA) has released a final guidance document with immediate effect advising sponsors on ...
Access to mifepristone, approved by FDA in 2000, is regulated by a "Risk Evaluation and Management Strategy" (REMS). Under ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results